GFM
RVMD icon

GF Fund Management’s Revolution Medicines RVMD Stock Holding History

GF Fund Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$786K Sell
4,195
-146
-3% -$21.3K 0.01% 195
2026
Q1 		$422K Buy
4,341
+543
+14% +$54.8K 0.01% 231
2025
Q4 		$303K Sell
3,798
-224
-6% -$14.7K 0.01% 254
2025
Q3 		$188K Sell
4,022
-285
-7% -$11.2K ﹤0.01% 297
2025
Q2 		$158K Hold
4,307
– – ﹤0.01% 339
2025
Q1 		$152K Buy
4,307
+775
+22% +$31.5K ﹤0.01% 337
2024
Q4 		$154K Buy
+3,532
New +$178K ﹤0.01% 304

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

GF Fund Management's RVMD Position: Q2 2026 in Review

GF Fund Management reduced its Revolution Medicines (RVMD) stake by 3.4% in Q2 2026, selling an estimated $21.3K and leaving 4,195 shares worth $786K. The position accounts for 0.01% of the portfolio, ranked #195.

GF Fund Management first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • GF Fund Management held 4,195 shares of Revolution Medicines worth $786K as of Q2 2026.
  • GF Fund Management sold 146 Revolution Medicines shares in Q2 2026, an estimated $21.3K.
  • Revolution Medicines made up 0.01% of GF Fund Management's portfolio in Q2 2026, its #195 holding.
  • GF Fund Management first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.